Neurogenic Bladder
📧 Sign up to get email alerts when something new happens for Neurogenic Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-10-27FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Advagen Pharma Limited)
FDA approved the generic oxybutynin chloride tablet from Advagen Pharma Limited under an Original Application.
-
FDA approval · 2017-10-24FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) filed by Allergan, Inc. This decision updates the product labeling.
-
FDA approval · 2014-07-18FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, Inc.
-
FDA approval · 2013-08-30FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC.
-
FDA approval · 2010-03-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Teva Pharmaceuticals USA, updating the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for oxybutynin chloride. This action confirms approval of changes to the ge…
-
FDA approval · 2007-02-01FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride (Strides Pharma Science Limited) under ANDA075079. This action authorizes th…